News
Market and company headlines
DDAll
Loading
18:00-22:00Oct 242 Stories
Is DuPont de Nemours (DD) Fully Priced After Its 72% Run?
DuPont de Nemours has delivered a strong multi‑year run, and with the stock recently closing at US$136.55, the question now is how well that price lines up with the cash the business is expected to generate. Investors have fresh product news to weigh against that share price, which puts the focus squarely on the value of DuPont's future cash flows rather than just the chart. Over the past 5 years the stock has returned 72.2%. That puts real pressure on the current valuation to be backed by...
Should Peptide Purification Launch Require Action From DuPont (DD) Investors?
DuPont de Nemours recently introduced AmberChrom SIL silica gel, a reverse phase silica media in C8 and C18 chemistries for demanding peptide purification, including GLP-1 receptor agonists. This expands its bioprocessing purification portfolio. The launch pushes DuPont de Nemours deeper into biopharma process consumables, an area where recurring demand and high purity requirements can help anchor long-term customer relationships. The focus now turns to how DuPont de Nemours' broader...
09:00-15:00Oct 242 Stories
DuPont De Nemours (DD) Expands Bioprocessing Tools, Is The Stock Still Cheap?
DuPont de Nemours (DD) just expanded its bioprocessing toolkit with AmberChrom SIL silica gel, a reverse phase media tailored for peptide therapeutics like GLP-1 receptor agonists. This development is putting fresh attention on how its healthcare solutions support complex drug manufacturing. Recent trading has leaned positive for DuPont de Nemours, with the share price at US$136.55 after a 1-day share price return of 1.07% and a 7-day share price return of 4.68%. A fresh product launch and an...
DuPont (DD) Launches AmberChrom SIL Silica Gel For Peptide Purification
DuPont de Nemours (NYSE:DD) introduced its AmberChrom SIL silica gel for peptide purification, expanding its bioprocessing portfolio. The AmberChrom SIL product is aimed at purification of peptide therapeutics used in treatments for diabetes, obesity, and oncology. The technology is designed to deliver high resolution, stability, and scalability while fitting into existing chromatography setups for manufacturers. AmberChrom SIL silica gel broadens DuPont's peptide purification reach, yet...
09:00Oct 231 Story
05:00-10:00Oct 222 Stories
DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics
DuPont (NYSE: DD) today announced the launch of DuPont™ AmberChrom™ SIL silica gel, a new reverse phase silica-based solution designed to support the purification and manufacture of peptide therapeutics, including glucagon-like peptide-1 (GLP-1) receptor agonists. The addition of AmberChrom™ SIL silica gel expands DuPont's bioprocessing purification portfolio with reverse phase silica technology designed for demanding peptide separations and final high-purity polishing.
DuPont Rolls Out DuPont AmberChrom SIL Silica Gel
DuPont (NYSE: DD) today announced the launch of DuPont™ AmberChrom™ SIL silica gel, a new reverse phase silica-based solution designed to support the purification and manufacture of peptide therapeutics, including
10:00Oct 191 Story
06:00Oct 151 Story
11:00Oct 141 Story
16:00-19:00Oct 132 Stories
Barclays Initiates Coverage of DuPont de Nemours at Overweight
DuPont Announces Regular Quarterly Dividend on Common Stock
DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on December 15, 2026, to holders of record of said stock at the close of business on November 30, 2026.
05:00Oct 131 Story
11:00Oct 91 Story
11:00Oct 71 Story
09:00-12:00Oct 62 Stories
Advanced Sports Materials - Global Strategic Business Report Released: Secure Your Share of the $3.0 Billion 2032 Market as BASF, DuPont, Hexcel, Mitsubishi Chemical, and Toray Accelerate Innovation
Capitalize on demand for lightweight, smart and sustainable materials across protective gear, sports equipment, apparel and footwear.Dublin, Oct. 06, 2026 (GLOBE NEWSWIRE) -- "Advanced Sports Materials - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global advanced sports materials market was estimated at US$2.3 billion in 2025 and is projected to reach US$3.0 billion by 2032, expanding at a compound annual growth rate (CAGR) of 4.0% during the foreca
Nelipak Wins 2026 DuPont™ Tyvek® Sustainable Healthcare Packaging Award for Sustainability In-use
Nelipak’s Ecovate™ header bag, featuring all-polyethylene construction and Tyvek® with Renewable Attribution, recognized for helping the growing ready-to-fill/use market advance packaging circularity.CRANSTON, R.I., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak®”), a leading global provider of healthcare packaging solutions, announced it has been named a Dupont™ Tyvek® Sustainable Healthcare Packaging Awards winner in the Sustainability In-Use category for its innovative Ecova
07:00Oct 61 Story
09:00-13:00Oct 52 Stories
UBS Maintains Buy on DuPont de Nemours, Lowers Price Target to $172
UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $178 to $172.
DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards
DuPont (NYSE: DD) announced the winners of its global awards program, the Tyvek® Sustainable Healthcare Packaging Awards, during the Medical Packaging Conference (MPC) hosted by DuPont September 30 - October 2, 2026, in Boston. Now in its third year, this awards program recognizes leaders across the healthcare industry who are embracing and driving sustainability throughout the packaging lifecycle.
07:00Oct 21 Story
18:00-22:00Sep 302 Stories
Can DuPont De Nemours (DD) Keep Trading Below Fair Value On Cash Flow?
DuPont de Nemours has delivered a strong multi year share price run, and the question now is whether the cash the business can generate really backs up where the stock trades today. With the focus squarely on its cash flows, investors are asking if the current valuation lines up with what the company can reasonably produce over time. Over the past 5 years the stock has returned 63.3%, which puts real weight on whether the underlying cash generation can support that kind of value...
Is DuPont De Nemours (DD) A Bargain After Its New Sugar Separation Tool?
What DuPont de Nemours’ New Sugar Tool Means For The Stock DuPont de Nemours (DD) has launched the Sugar Separation Advisor, a digital tool that helps sugar and sweetener producers quickly assess chromatographic separation options and shortlist AmberLite resins based on lab generated data. Recent trading tells a mixed story for DuPont de Nemours. The share price is down over the past month and quarter, yet the year to date share price return is 5.94% and the 1 year total shareholder return is...
09:00Sep 301 Story
07:00-10:00Sep 282 Stories
Photoactive Materials Market - Global Strategic Business Report: Capitalize on the $1.2 Billion 2030 Revenue Shift as Organic Materials Hit $873 Million and BASF, DuPont, Merck KGaA and Oxford Photovoltaics Race to Dominate
Demand is rising across solar, wearables, sensors and precision medicine, while nanostructuring and safer, durable materials enable smart coatings and light-powered devices.Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Photoactive Materials Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Photoactive Materials Market to Reach US$1.2 Billion by 2030 as Energy, Healthcare and Sensing Applications Expand The global photoactive materials market was
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap CNXN, ECG, GRDN, EXPD and PBF.
09:00-11:00Sep 244 Stories
DuPont: Secular Growth And Margin Expansion Should Drive Good Upside
Buy DuPont (DD) stock: secular growth in healthcare, water tech, EV and aerospace plus margin expansion. Read the full analysis here.
Low Dielectric Materials Market Forecasts Growth from $3.10B (2025) to $4.29B by 2030, Profiling Daikin, DuPont, Shin-Etsu Chemical & Toray Industries
Opportunities span advanced chips, high-speed PCBs, 5G/6G, AI data centers, EV radar, aerospace, satellites and defense, driving demand for durable, sustainable low-loss materials.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Low Dielectric Materials Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Low Dielectric Materials Market research report examines the technologies, applications, competitive factors, and regional trends shaping this strategically i
06:00-10:00Sep 172 Stories
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now
DD's innovation, acquisitions and productivity gains support growth, but uneven construction demand and higher input costs weigh on margins.
Did Chemours' (CC) US$455 Million PFAS Deal Just Reframe Its Long‑Term Liability Narrative?
On September 9, 2026, Chemours, DuPont, and Corteva reached a settlement with North Carolina and 11 nearby local entities, agreeing to pay US$455 million over 15 years to resolve PFAS-related claims tied to Chemours’ Fayetteville Works facility and other contamination issues. The agreement not only clears a significant portion of Chemours’ legacy PFAS exposure but also introduces a shared, net-present-value framework under the companies’ existing US$4.00 billion cost-sharing cap, potentially...
10:00Sep 161 Story
08:00-15:00Sep 113 Stories
Chemours, DuPont, Corteva settle North Carolina PFAS claims for $455M
Payments will be made over 15 years to the state and 11 local communities excluded from a 2024 national water system settlement
Is DuPont de Nemours Stock Outperforming the Dow?
DuPont de Nemours has outperformed the Dow over the past year, and analysts are highly optimistic about the stock’s prospects.
12:00-14:00Sep 102 Stories
Groundbreaking for $669M East Coast container terminal
Delaware Container Terminal is scheduled to open by 2028. The post Groundbreaking for $669M East Coast container terminal appeared first on FreightWaves.
Why Is Chemours Stock Trading Higher Today?
The Chemours Company (NYSE:CC) shares traded higher Thursday after the company, DuPont, and Corteva reached a $455 million settlement resolving PFAS-related litigation in North Carolina. The gain came despite broader weakness, with the S&P 500 down 0.43% and the Materials sector falling 1.24%. Chemours’ Share Covered By Existing Accruals Chemours, DuPont de Nemours, Inc. (NYSE:DD), and Corteva, Inc. (NYSE:CTVA) reached a $455 million settlement with North Carolina and 11 local entities over PFAS
07:00-11:00Sep 102 Stories
Chemours Shares Rise 6% After $455 Million North Carolina PFAS Settlement
Chemours (NYSE:CC) shares rose 6% on Thursday after the company announced a settlement with the State of North Carolina and 11 local entities covering PFAS-related claims. The agreement resolves litigation concerning PFAS and other historical discharges from the Fayetteville Works facility, as well as claims involving alleged PFAS contamination unrelated to the site, including the use of aqueous film forming foam.
DuPont, Chemours and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina
DuPont (NYSE: DD) today announced that, together with The Chemours Company ("Chemours"), and Corteva Inc. and its subsidiary EIDP Inc. (formerly known as E. I. du Pont de Nemours and Company and together with its parent, Corteva Inc., referred to as "Corteva"), it has entered into a settlement (the "Settlement") with the State of North Carolina and 11 local entities* in the vicinity of the Company's Fayetteville Works facility that were excluded from the U.S. Public Water System Class Settlement
06:00Sep 101 Story
09:00Aug 131 Story
07:00-23:00Aug 122 Stories
Your Will Doesn’t Decide Who Gets Your 401(k) or IRA. A One-Page Form You Signed Decades Ago Does, and It Beats the Will in Court Every Time
A one-page form you signed on your first day at a job quietly controls who inherits your retirement savings, and it can hand everything to the wrong person no matter what your will says.
DuPont de Nemours Stock: Analyst Estimates & Ratings
DuPont de Nemours has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
09:00-13:00Aug 112 Stories
DuPont (DD) Q2 2026 Earnings Call Transcript
Strong semiconductor and aerospace demand drive guidance raise for full year.
Australia's Largest Inland Wastewater Treatment Facility Selects MemCor™ MBR System for Expansion
DuPont (NYSE: DD) today announced that a MemCor™ membrane bioreactor (MBR) system has been selected to support the upgrade of the Lower Molonglo Water Quality Control Centre (LMWQCC) in Canberra, Australia, the largest inland wastewater treatment facility in the country. The MemCor™ MBR system will significantly expand treatment capacity and continue to produce high quality effluent for safe discharge.